Effect of an Olmesartan Medoxomil-Based Treatment Algorithm on Systolic Blood Pressure in Patients with Stage 1 or 2 Hypertension

@article{Kereiakes2010EffectOA,
  title={Effect of an Olmesartan Medoxomil-Based Treatment Algorithm on Systolic Blood Pressure in Patients with Stage 1 or 2 Hypertension},
  author={Dean J Kereiakes and Jen-fue Maa and Ali Shojaee and Robert Dubiel},
  journal={American Journal of Cardiovascular Drugs},
  year={2010},
  volume={10},
  pages={239-246}
}
Background and ObjectiveElevated systolic BP (SBP) is a major contributor to cardiovascular disease. SBP control reduces the occurrence of stroke, heart failure, and cardiovascular and total mortality. The aim of this study was to analyze the magnitude of SBP reductions and the achievement of individual SBP targets in the original BENIFORCE study.MethodsAn olmesartan medoxomil-based treatment algorithm was evaluated in a double-blind, placebo-controlled titration study in 276 patients with… CONTINUE READING

Citations

Publications citing this paper.